Home/ Stocks/ ABT

Abbott Laboratories

ABT XNYS

$103.14 +1.22 (+1.19%) ▲ 15-min delayed

Open

$103.56

High

$104.44

Low

$102.57

Volume

3.60M

Market Cap

$176.41B

About Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 115.0K Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$12.59B	$928.00M	$0.53
Q1 2026	$11.16B	$1.08B	$0.62
FY 2025	$44.33B	$6.52B	$3.73
Q2 2025	$11.14B	$1.78B	$1.02

TickerDaily Coverage

Stock Market Today, July 5, 2026: Banking Giants, Healthcare Leaders Kick Off Earnings Week

Market News David Brooks · Jul 6, 2026

With markets closed Sunday, July 5, 2026, traders are preparing for one of the heaviest earnings...

Pre-Market Movers: Top 5 Stocks Making Biggest Moves Before Bell on June 16

Market News Sarah Mitchell · Jun 16, 2026

Five major stocks are making significant pre-market moves on Tuesday, June 16, 2026, driven by...

View All Coverage →

Get ABT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Abbott Laboratories.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.